These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10577660)

  • 21. Two drugs reduce transmission.
    AIDS Patient Care STDS; 2002 Sep; 16(9):462. PubMed ID: 12412582
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
    Kazennova EV
    Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
    Jackson JB; Parsons T; Musoke P; Nakabiito C; Donnell D; Fleming T; Mirochnick M; Mofenson L; Fowler MG; Mmiro F; Guay L
    AIDS; 2006 Jan; 20(2):217-22. PubMed ID: 16511414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
    Herzmann C; Karcher H
    N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729
    [No Abstract]   [Full Text] [Related]  

  • 26. Reports on nevirapine threaten public health.
    Lane HC; Folkers GK; Fauci AS
    Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930
    [No Abstract]   [Full Text] [Related]  

  • 27. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 29. Averting drug resistance while preventing MTCT.
    AIDS Read; 2005 Apr; 15(4):150-1. PubMed ID: 15846848
    [No Abstract]   [Full Text] [Related]  

  • 30. HIVNET nevirapine trials.
    Hudson CP; Moodley J
    Lancet; 1999 Nov; 354(9192):1817-8. PubMed ID: 10577662
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antiviral agents for reduction of mother-to-child transmission of HIV infection].
    Bruun JN
    Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2041-2. PubMed ID: 12934126
    [No Abstract]   [Full Text] [Related]  

  • 32. Unequal care sustains vertical transmission rate.
    Kasper T
    GMHC Treat Issues; 1999 Feb; 13(2):11-2. PubMed ID: 11366115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast milk HIV-1 suppression and decreased transmission: a randomized trial comparing HIVNET 012 nevirapine versus short-course zidovudine.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; John-Stewart GC
    AIDS; 2005 Sep; 19(13):1415-22. PubMed ID: 16103773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
    Pilger D; Hauser A; Kuecherer C; Mugenyi K; Kabasinguzi R; Somogyi S; Harms G; Kunz A
    Antivir Ther; 2011; 16(1):109-13. PubMed ID: 21311114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
    Kuhn L; Sinkala M; Kankasa MP; Kasonde P; Thea DM; Aldrovandi GM
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):260-2. PubMed ID: 16760802
    [No Abstract]   [Full Text] [Related]  

  • 36. Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda?
    Kironde S; Lukwago J; Ssenyonga R
    Afr Health Sci; 2003 Aug; 3(2):102-3. PubMed ID: 12913802
    [No Abstract]   [Full Text] [Related]  

  • 37. The controversies of nevirapine for preventing mother-to-child HIV transmission.
    Smith DM
    AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prevention of mother-child HIV transmission: a shortened and simplified zidovudine treatment].
    Sante; 2000; 10(6):406. PubMed ID: 11345936
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV: mother to child transmission.
    Volmink J
    Clin Evid; 2003 Jun; (9):785-94. PubMed ID: 12967392
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduction of HIV-1 drug resistance after intrapartum single-dose nevirapine.
    Lockman S; McIntyre JA
    Lancet; 2007 Nov; 370(9600):1668-70. PubMed ID: 17997152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.